Studies mechanisms of endothelial and podocyte dysfunction—ER stress, mitochondrial/redox imbalance and inflammatory signalling—connecting microbiome‑derived metabolites to vascular risk, and evaluating drug‑induced effects and protective strategies to guide translational cardiovascular, renal and clinical pharmacology.